ASN Kidney Week 2024
Advertisement
Aquapheresis may provide an alternative for fluid removal in hypervolemia patients with sickle cell nephropathy.
Researchers reported on a patient with elevated 1,25-dihydroxyvitamin D with hypercalcemia and severe tophaceous gout.
A case report suggests treatment with intravenous pegloticase could help eGFR recovery in patients with uncontrolled gout.
A study examined gout incidence and risk among stage 3-5 CKD patients with asymptomatic hyperuricemia.
A study examined the prevalence, patient characteristics, and medical management of patients with gout and CKD.
A patient with gout experienced an increased risk of kidney stone formation after adopting a carnivore diet.
Researchers presented bone-related findings of a study on pegloticase use in kidney transplant recipients with gout.
Researchers explored an association between fluctuating uric acid levels and adverse prognoses in older adults with CKD.
A study examined the association between the prescription of ULT and the progression of kidney disease in patients with CKD.
Lupkynis for lupus nephritis is the focus of six accepted abstracts at the American Society of Nephrology Kidney Week 2024.
The American Society of Nephrology published the abstracts for Kidney Week 2024.
A late-breaking abstract at Kidney Week will report on a phase 3 trial of the ATEV in AV access for patients with ESRD.
Long-term results of a study of atacicept to treat IgA nephropathy (IgAN) will be presented at ASN Kidney Week.
ASN Kidney Week 2024 early programs take place October 23 and offer the chance to earn continuing education credits.
Three posters related to Unicycive's drug candidates for kidney diseases will be presented at ASN Kidney Week 2024.
Research on xanthine oxidase activity in polycystic kidney disease sponsored by XORTX will be presented at ASN Kidney Week.
The American Society of Nephrology (ASN) announced the plenary keynote speakers for its 2024 Kidney Week event.
Advertisement
630 Madison Ave.
Manalapan, NJ 07726
© 2024 Mashup Media, LLC, a Formedics Property. All Rights Reserved.